ArticleCellular & molecular biology letters2012

Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells.

Jurate Savickiene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.